# Mytide Therapeutics, Inc. — Form D/A

Mytide Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2022-06-07. The offering totals $7.1M, of which $7.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-06-07
- Form: D/A
- Accession: 0001567619-22-012414
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.1M
- Amount sold: $7.1M
- Investors: 23
- Date of first sale: 2021-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-430375

## Issuer

- Name: Mytide Therapeutics, Inc.
- CIK: 0001905245
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 451 D STREET SUITE 707, BOSTON, MA, 02210
- Phone: (207) 659-4206

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Errik Anderson | Director | Cambridge, MA |
| Jason Norris | Director | Cambridge, MA |
| Jason Norris | Executive Officer | Cambridge, MA |
| Jason Norris | Promoter | Cambridge, MA |
| Dale Thomas | Director | Boston, MA |
| Dale Thomas | Executive Officer | Boston, MA |
| Dale Thomas | Promoter | Boston, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-01-06](https://search.stillhousedata.com/formd/0001567619-23-000625) | D | $2.5M | $1.2M |
| [2022-01-21](https://search.stillhousedata.com/formd/0001567619-22-001406) | D | $7.1M | $6.6M |

## More

- [CIK 1905245 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1905245&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-22-012414.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.